Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Return on Sales (2016 - 2025)

Biomerica's Return on Sales history spans 16 years, with the latest figure at 1.09% for Q4 2025.

  • For Q4 2025, Return on Sales fell 51.0% year-over-year to 1.09%; the TTM value through Nov 2025 reached 0.9%, up 10.0%, while the annual FY2025 figure was 0.94%, 17.0% up from the prior year.
  • Return on Sales for Q4 2025 was 1.09% at Biomerica, down from 0.0% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.0% in Q3 2025 and bottomed at 6.33% in Q2 2021.
  • The 5-year median for Return on Sales is 1.06% (2025), against an average of 1.22%.
  • The largest annual shift saw Return on Sales plummeted -603bps in 2021 before it surged 601bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 0.24% in 2021, then tumbled by -353bps to 1.1% in 2022, then grew by 12bps to 0.96% in 2023, then soared by 40bps to 0.58% in 2024, then tumbled by -88bps to 1.09% in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Return on Sales are 1.09% (Q4 2025), 0.0% (Q3 2025), and 2.06% (Q2 2025).